JPMorgan Chase & Co’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.1M | Sell |
|
|||||
|
2025
Q1 | $147M | Sell |
|
|||||
|
2024
Q4 | $265M | Sell |
|
|||||
|
2024
Q3 | $291M | Buy |
|
|||||
|
2024
Q2 | $301M | Sell |
|
|||||
|
2024
Q1 | $398M | Buy |
|
|||||
|
2023
Q4 | $310M | Sell |
|
|||||
|
2023
Q3 | $341M | Sell |
|
|||||
|
2023
Q2 | $362M | Buy |
|
|||||
|
2023
Q1 | $294M | Buy |
|
|||||
|
2022
Q4 | $115M | Buy |
|
|||||
|
2022
Q3 | $54.5M | Sell |
|
|||||
|
2022
Q2 | $68.8M | Sell |
|
|||||
|
2022
Q1 | $120M | Buy |
|
|||||
|
2021
Q4 | $130M | Buy |
|
|||||
|
2021
Q3 | $99.3M | Sell |
|
|||||
|
2021
Q2 | $113M | Sell |
|
|||||
|
2021
Q1 | $90.1M | Buy |
|
|||||
|
2020
Q4 | $71.4M | Sell |
|
|||||
|
2020
Q3 | $98.9M | Sell |
|
|||||
|
2020
Q2 | $184M | Sell |
|
|||||
|
2020
Q1 | $150M | Sell |
|
|||||
|
2019
Q4 | $203M | Sell |
|
|||||
|
2019
Q3 | $216M | Sell |
|
|||||
|
2019
Q2 | $192M | Sell |
|
|||||
|
2019
Q1 | $171M | Sell |
|
|||||
|
2018
Q4 | $159M | Sell |
|
|||||
|
2018
Q3 | $202M | Sell |
|
|||||
|
2018
Q2 | $183M | Sell |
|
|||||
|
2018
Q1 | $163M | Sell |
|
|||||
|
2017
Q4 | $183M | Buy |
|
|||||
|
2017
Q3 | $178M | Sell |
|
|||||
|
2017
Q2 | $190M | Sell |
|
|||||
|
2017
Q1 | $166M | Buy |
|
|||||
|
2016
Q4 | $157M | Buy |
|
|||||
|
2016
Q3 | $101M | Buy |
|
|||||
|
2016
Q2 | $96.6M | Buy |
|
|||||
|
2016
Q1 | $80.5M | Buy |
|
|||||
|
2015
Q4 | $67.1M | Sell |
|
|||||
|
2015
Q3 | $68.6M | Sell |
|
|||||
|
2015
Q2 | $74.8M | Sell |
|
|||||
|
2015
Q1 | $78.8M | Buy |
|
|||||
|
2014
Q4 | $65M | Buy |
|
|||||
|
2014
Q3 | $53.4M | Buy |
|
|||||
|
2014
Q2 | $49.8M | Buy |
|
|||||
|
2014
Q1 | $44.1M | Buy |
|
|||||
|
2013
Q4 | $20.9M | Buy |
|
|||||
|
2013
Q3 | $17M | Buy |
|
|||||
|
2013
Q2 | $3.96M | Buy |
|